Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.526NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.279NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.51NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XATNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.85NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.65NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BG.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.61NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.74NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.62NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.13.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAZNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.290NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.341NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.161NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.69 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.46NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.139NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.508NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.94NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.463NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.357NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.318NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.557NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.119NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.160NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
D.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.447NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.110.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.180NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used